COLL
COLLEGIUM PHARMACEUTICAL, INC · Healthcare · Market cap $766.0M(Price slightly stale)
Insiders sold $1.1M net in the last 90 days ·4 sellers, 0 buyers· 1 of 5 sales under Rule 10b5-1 plans· latest Form 4 filed May 20, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7.2M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Latest filing
Jun 10, 2026
Freund John Gordon
COLLEGIUM PHARMACEUTICAL, INC (COLL) has 25 SEC Form 4 filings (47 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Jun 10, 2026.
Inside the rolling window, 8 insiders at COLLEGIUM PHARMACEUTICAL, INC reported no open-market purchases and 11 open-market sales totaling $7.2M. Insiders have net sold $3.4M over the trailing 6 months. The most recent open-market filing is a sale of 20 shares by Director Freund John Gordon, dated May 18, 2026, worth $681.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Vikram Karnani
- Employees:423
- HQ:Stoughton, MA, US
- IPO:2015-05-07
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Director | Sale | 20 | $681 | May 20 | -31.2% | SEC ↗ | |
Freund John GordonFirst filing | Director | Sale | 4,127 | $143K | May 18 | -30.1% | SEC ↗ |
Lurker NancyFirst in 5 months | Director | Sale | 4,500 | $162K | May 15 | -30.3% | SEC ↗ |
BOHLIN GAREN GFirst filing | Director | Sale | 8,700 | $323K | May 13 | -32.5% | SEC ↗ |
| EVP & General Counsel | Sale | 13,976 | $488K | Mar 20 | -33.6% | SEC ↗ | |
Dieter DavidFirst filing | EVP & General Counsel | Sale | 6,224 | $228K | Mar 11 | -33.9% | SEC ↗ |
| EVP & Chief Commercial Officer | Sale | 49,976 | $2.0M | Mar 5 | -36.9% | SEC ↗ | |
Dreyer ScottFirst filing | EVP & Chief Commercial Officer | Sale | 17,600 | $848K | Dec 10 | -51.8% | SEC ↗ |
Balice-Gordon Rita J.First filing | Director | Sale | 3,650 | $172K | Dec 9 | — | SEC ↗ |
Fallon John A.First filing | Director | Sale | 34,853 | $1.6M | Nov 14 | — | SEC ↗ |
Tupper ColleenFirst filing | EVP & Chief Financial Officer | Sale | 30,000 | $1.2M | Nov 7 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does COLL have?
COLLEGIUM PHARMACEUTICAL, INC (COLL) has 25 SEC Form 4 filings (47 transaction rows) in the rolling 365-day window, disclosed by 8 distinct insiders. Most recent filing: Jun 10, 2026.
When was the most recent SEC Form 4 filing for COLL?
The most recent Form 4 filing for COLL on Tracefour is dated Jun 10, 2026.
What is the net insider flow at COLL over the last 6 months?
Over the trailing 180 days, insiders at COLL have net sold $3.4M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at COLL in the current window?
Inside the rolling window, insiders at COLL bought $0 and sold $7.2M based on SEC Form 4 filings.
Can I get alerts for COLL insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at COLLEGIUM PHARMACEUTICAL, INC (COLL). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
COLLEGIUM PHARMACEUTICAL, INC is in the Healthcare sector.